We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
+8.61%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$14.8B
AUM Growth
+$1.53B
(+12%)
Cap. Flow
+$575M
Cap. Flow
% of AUM
3.88%
Top 10 Holdings %
Top 10 Hldgs %
20.47%
Holding
2,662
New
208
Increased
1,251
Reduced
990
Closed
149
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$56.7M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$43.4M |
| 3 |
Vanguard Extended Market ETF
VXF
|
+$41.1M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$39.4M |
| 5 |
Apple
AAPL
|
+$35.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
C.H. Robinson
CHRW
|
+$26.2M |
| 2 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$25.5M |
| 3 |
Pacer Trendpilot US Large Cap ETF
PTLC
|
+$20.6M |
| 4 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$18.6M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$15M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.79% |
| 2 | Consumer Discretionary | 5% |
| 3 | Healthcare | 4.52% |
| 4 | Financials | 4.2% |
| 5 | Communication Services | 3.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Hershey
HSY
$37B
| $6.14M | 0.04% |
42,868
+1,184
| +3% | +$168K |
|
402
Ecolab
ECL
$78.1B
| $6.14M | 0.04% |
30,731
+4,616
| +18% | +$922K |
|
403
TSMC
TSM
$2.23T
| $6.13M | 0.04% |
75,671
+34,771
| +85% | +$2.64M |
|
404
Schwab U.S Small- Cap ETF
SCHA
$23.3B
| $6.13M | 0.04% |
358,744
-33,068
| -8% | -$569K |
|
405
Bath & Body Works
BBWI
$3.65B
| $6.11M | 0.04% |
237,468
+218,657
| +1,162% | +$4.47M |
|
406
Regeneron Pharmaceuticals
REGN
$82.2B
| $6.1M | 0.04% |
10,904
-3,981
| -27% | -$2.41M |
|
407
Edwards Lifesciences
EW
$53.6B
| $6.03M | 0.04% |
75,538
+4,447
| +6% | +$347K |
|
408
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.44B
| $6.01M | 0.04% |
196,374
-35,054
| -15% | -$1.08M |
|
409
First Trust Managed Municipal ETF
FMB
$2.06B
| $6M | 0.04% |
107,956
+5,956
| +6% | +$332K |
|
410
Lam Research
LRCX
$408B
| $5.98M | 0.04% |
180,210
+75,760
| +73% | +$2.61M |
|
411
John Hancock Multifactor Large Cap ETF
JHML
$1.2B
| $5.97M | 0.04% |
142,911
-2,479
| -2% | -$102K |
|
412
Delta Air Lines
DAL
$59.1B
| $5.95M | 0.04% |
194,705
+17,129
| +10% | +$494K |
|
413
Eaton Vance Tax-Managed Diversified Equity Income Fund
ETY
$2.35B
| $5.93M | 0.04% |
544,542
-15,482
| -3% | -$172K |
|
414
Cummins
CMI
$87.8B
| $5.85M | 0.04% |
27,705
-574
| -2% | -$114K |
|
|
WRK
415
DELISTED
WestRock Company
WRK
| $5.84M | 0.04% |
168,112
-3,995
| -2% | -$123K |
|
416
Novartis
NVS
$290B
| $5.8M | 0.04% |
66,672
+3,594
| +6% | +$311K |
|
|
SCHV
417
Schwab US Large-Cap Value ETF
SCHV
$16.3B
| $5.8M | 0.04% |
333,177
-195,738
| -37% | -$3.42M |
|
418
BlackRock US Equity Factor Rotation ETF
DYNF
$40.3B
| $5.78M | 0.04% |
206,355
-3,634
| -2% | -$101K |
|
419
iShares Russell 2000 Value ETF
IWN
$14.6B
| $5.75M | 0.04% |
57,858
-14,710
| -20% | -$1.49M |
|
|
WBA
420
DELISTED
Walgreens Boots Alliance
WBA
| $5.72M | 0.04% |
159,303
+10,970
| +7% | +$429K |
|
421
Renaissance IPO ETF
IPO
$163M
| $5.71M | 0.04% |
+109,174
| New | +$5.01M |
|
422
Consolidated Edison
ED
$39.9B
| $5.7M | 0.04% |
73,309
+8,532
| +13% | +$630K |
|
423
WisdomTree US MidCap Fund
EZM
$957M
| $5.63M | 0.04% |
164,741
-16,734
| -9% | -$576K |
|
424
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.6B
| $5.57M | 0.04% |
100,913
-71,820
| -42% | -$3.96M |
|
425
Fidelity National Information Services
FIS
$21.6B
| $5.55M | 0.04% |
37,673
+1,859
| +5% | +$269K |
|
Similar funds
LP
TI
Cambridge Investment Research Advisors's Q3 2020 Portfolio in Review
As of Q3 2020, Cambridge Investment Research Advisors held 2,662 positions worth $14.8B, up 12% from $13.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Cambridge Investment Research Advisors deployed $575M of net new capital in Q3 2020, opening 208 new positions and adding to 1,251 existing holdings. Its largest new stake was Invesco Building & Construction ETF: 187,041 shares worth $6.78M.
By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was C.H. Robinson, an estimated $26.2M trimmed.
- Cambridge Investment Research Advisors's largest Q3 2020 buy was Invesco Building & Construction ETF: 187,041 shares worth $6.78M.
- Cambridge Investment Research Advisors added most to Bristol-Myers Squibb in Q3 2020, an estimated $56.7M increase.
- Cambridge Investment Research Advisors's biggest Q3 2020 reduction was C.H. Robinson, cutting an estimated $26.2M.
- Cambridge Investment Research Advisors fully exited WisdomTree International ESG Fund in Q3 2020, selling an estimated $11.4M.
- Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $14.8B portfolio in Q3 2020.
- Cambridge Investment Research Advisors opened 208 new positions and closed 149 in Q3 2020.
- Cambridge Investment Research Advisors's portfolio value rose 12% quarter-over-quarter to $14.8B.
Based on Cambridge Investment Research Advisors's 13F filing for Q3 2020, filed 29 Oct 2020.